Therapy-related myelodysplastic syndrome: a retrospective analysis of data from the Czech Working MDS Group registry

Abstract

The development of therapy-related myelodysplastic syndrome occurs after exposure to cytotoxic agents and represents the serious long-term complication associated with current cancer therapy. The Czech MDS Study Group retrospectively analyzed these patients.

In our registry we identified 111 patients (70 women, 41 men) with MDS.

Keywords

• secondary myelodysplastic syndrome
• therapy-related myelodysplastic syndrome